Twist Bioscience Corporation (TWST)
NASDAQ: TWST · IEX Real-Time Price · USD
58.08
+0.57 (0.99%)
At close: Jul 26, 2024, 4:00 PM
60.90
+2.82 (4.86%)
After-hours: Jul 26, 2024, 4:41 PM EDT
Twist Bioscience Market Cap
Twist Bioscience has a market cap or net worth of $3.38 billion as of July 26, 2024. Its market cap has increased by 154.96% in one year.
Market Cap
3.38B
Enterprise Value
3.16B
1-Year Change
154.96%
Ranking
Category
Stock Price
$58.08
Market Cap Chart
Since October 31, 2018, Twist Bioscience's market cap has increased from $372.50M to $3.38B, an increase of 807.86%. That is a compound annual growth rate of 46.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 3.35B | 57.51% |
| Dec 29, 2023 | 2.13B | 57.84% |
| Dec 30, 2022 | 1.35B | -64.93% |
| Dec 31, 2021 | 3.84B | -39.79% |
| Dec 31, 2020 | 6.38B | 817.27% |
| Dec 31, 2019 | 695.50M | 7.78% |
| Dec 31, 2018 | 645.30M | 73.23% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Denali Therapeutics | 3.37B |
| GoodRx Holdings | 3.37B |
| Arcellx | 3.32B |
| Xenon Pharmaceuticals | 3.30B |
| HUTCHMED (China) | 3.27B |
| Inari Medical | 3.22B |
| Oscar Health | 3.21B |
| Amedisys | 3.19B |